BIOLOGICAL THERAPIES B-DOSE 2mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies b-dose 2ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

BIOLOGICAL THERAPIES IV B-DOSE 2mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies iv b-dose 2ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

BIOLOGICAL THERAPIES B-DOSE FORTE 2.5mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

biological therapies b-dose forte 2.5ml injection vial

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

B-Dose 2mL Injection Australia - English - Department of Health (Therapeutic Goods Administration)

b-dose 2ml injection

dexpanthenol; cyanocobalamin; nicotinamide; thiamine hydrochloride; pyridoxine hydrochloride; riboflavine sodium phosphate -

CERNEVIT multivitamin powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cernevit multivitamin powder for injection vial

baxter healthcare pty ltd - riboflavine sodium phosphate, quantity: 5.67 mg; pyridoxine hydrochloride, quantity: 5.5 mg; cyanocobalamin, quantity: 6 microgram; nicotinamide, quantity: 46 mg; dl-alpha-tocopherol, quantity: 10.2 mg; ascorbic acid, quantity: 125 mg; retinol palmitate, quantity: 3500 iu; colecalciferol, quantity: 5.5 microgram; dexpanthenol, quantity: 16.15 mg; biotin, quantity: 69 microgram; cocarboxylase tetrahydrate, quantity: 5.8 mg (equivalent: thiamine, qty 3.51 mg); folic acid, quantity: 414 microgram - injection, powder for - excipient ingredients: glycine; glycocholic acid; hydrochloric acid; sodium hydroxide; lecithin - cernevit is indicated in adults and children over 11 years of age requiring parenteral multivitamin supplementation to correct or prevent vitamin deficiencies when oral administration is contraindicated, impossible or insufficient. the product does not contain vitamin k, which may be given separately if required.

THIAMINE- thiamine hydrochloride injection, solution United States - English - NLM (National Library of Medicine)

thiamine- thiamine hydrochloride injection, solution

fresenius kabi usa, llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.  thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke’s encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe.  it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption.  thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually b

THIAMINE- thiamine hydrochloride injection, solution United States - English - NLM (National Library of Medicine)

thiamine- thiamine hydrochloride injection, solution

fresenius kabi usa, llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety.  thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke’s encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe.  it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption.  thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually b

THIAMINE HYDROCHLORIDE injection, solution United States - English - NLM (National Library of Medicine)

thiamine hydrochloride injection, solution

general injectables & vaccines, inc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke's encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption. thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be g

THIAMINE HYDROCHLORIDE injection, solution United States - English - NLM (National Library of Medicine)

thiamine hydrochloride injection, solution

mylan institutional llc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j) - thiamine hydrochloride 100 mg in 1 ml - thiamine hydrochloride injection is effective for the treatment of thiamine deficiency or beriberi whether of the dry (major symptoms related to the nervous system) or wet (major symptoms related to the cardiovascular system) variety. thiamine hydrochloride injection should be used where rapid restoration of thiamine is necessary, as in wernicke’s encephalopathy, infantile beriberi with acute collapse, cardiovascular disease due to thiamine deficiency, or neuritis of pregnancy if vomiting is severe. it is also indicated when giving iv dextrose to individuals with marginal thiamine status to avoid precipitation of heart failure. thiamine hydrochloride injection is also indicated in patients with established thiamine deficiency who cannot take thiamine orally due to coexisting severe anorexia, nausea, vomiting, or malabsorption. thiamine hydrochloride injection is not usually indicated for conditions of decreased oral intake or decreased gastrointestinal absorption, because multiple vitamins should usually be g

AMINOPLEX INJECTION Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

aminoplex injection

jurox pty limited - dexpanthenol; glycine; lysine-l hydrochloride; methionine-dl; arginine-l hydrochloride; choline bitartrate; inositol; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b2 as phosphate sodium = riboflavin as phosphate; vitamin b1 hydrochloride = thiamine hydrochloride; vitamin b6 hydrochloride = pyridoxine hydrochloride - parenteral liquid/solution/suspension - dexpanthenol ungrouped active 20.0 mg/ml; glycine amino acid-glycine active 20.0 mg/ml; lysine-l hydrochloride amino acid-lysine-l active 20.0 mg/ml; methionine-dl amino acid-methionine-dl active 20.0 mg/ml; arginine-l hydrochloride amino acid-arginine-l active 20.0 mg/ml; choline bitartrate vitamin-b complex active 5.0 mg/ml; inositol vitamin-b complex active 10.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 0.2 mg/ml; vitamin b3 = nicotinamide vitamin-b3 active 60.0 mg/ml; vitamin b2 as phosphate sodium = riboflavin as phosphate vitamin-b2 active 5.0 mg/ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 20.0 mg/ml; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 active 20.0 mg/ml - nutrition & metabolism - cat | cattle | dog | horse | beef | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castrate | cat - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies